Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54,486,781
-
Number of holders
-
177
-
Total 13F shares, excl. options
-
45,670,504
-
Shares change
-
+854,495
-
Total reported value, excl. options
-
$335,708,725
-
Value change
-
+$1,389,547
-
Put/Call ratio
-
106%
-
Number of buys
-
79
-
Number of sells
-
-99
-
Price
-
$7.35
Significant Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q2 2023
217 filings reported holding EBS - Emergent BioSolutions Inc. - Common Stock as of Q2 2023.
Emergent BioSolutions Inc. - Common Stock (EBS) has 177 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45,670,504 shares
of 54,486,781 outstanding shares and own 84% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9,231,728 shares), STATE STREET CORP (6,794,144 shares), VANGUARD GROUP INC (4,342,342 shares), DIMENSIONAL FUND ADVISORS LP (1,489,585 shares), MILLENNIUM MANAGEMENT LLC (1,282,274 shares), JACOBS LEVY EQUITY MANAGEMENT, INC (1,234,447 shares), HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC (1,134,420 shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (1,078,418 shares), D. E. Shaw & Co., Inc. (977,917 shares), and GEODE CAPITAL MANAGEMENT, LLC (924,484 shares).
This table shows the top 177 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.